Treatment of eosinophilic pustular folliculitis with tacrolimus ointment - 24/08/11
Doi : 10.1016/j.jaad.2004.03.050
Dai Hara, MD, Kei Kuroda, MD, PhD ⁎ 
, Hideki Mieno, MD, Shingo Tajima, MD, PhD
, Hideki Mieno, MD, Shingo Tajima, MD, PhD From the Department of Dermatology, National Defence Medical College Japan
Reprint requests: Kei Kuroda, MD, PhD, Department of Dermatology, National Defence Medical College, 3-2 Namiki, Tokorozawa 359-8513, Japan.Tokorozawa, Japan
Abstract |
We describe a patient with eosinophilic pustular folliculitis who partially responded to oral indomethacin, but intermittently experienced new eosinophilic pustular folliculitis lesions. Treatment with tacrolimus ointment 0.1% resulted in the rapid improvement of each recurred lesion and allowed withdrawal of indomethacin. To our knowledge, this is the first report of the use of topical tacrolimus in the treatment of eosinophilic pustular folliculitis.
Le texte complet de cet article est disponible en PDF.Plan
 | The pagination of this article was incorrect as originally published (2004:51;S71-S73). Please use the corrected page numbers listed online at www.eblue.org, in the corrected table of contents, or in the December 2004 index in future citations. This supplement is made possible through the generous support of Stiefel Laboratories for the American Academy of Dermatology. Funding sources: None. Conflicts of interest: None identified. |
© 2004
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 51 - N° 5S
P. S143-S145 - novembre 2004 Retour au numéro
Article précédent
- Rickettsialpox: Report of three cases and a review
- Ritu Saini, John C. Pui, Susan Burgin
- Primary carcinoid tumor of the skin
- Clara-Dina Cokonis, Justin J. Green, Steven M. Manders
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?